TuHURA Biosciences (HURA) Share-based Compensation (2012 - 2026)

TuHURA Biosciences' Share-based Compensation history runs 15 years deep, the most recent figure standing at $21.4 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 1402.03% year-over-year to $21.4 million; the TTM figure through Mar 2026 stood at $21.4 million (up 622.07% YoY), while the FY2025 annual figure was $21.5 million, up 50.35% from the prior year.
• Share-based Compensation for Q1 2026 stood at $21.4 million, up from -$4.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $21.4 million in Q1 2026, with the low at -$4.1 million in Q4 2025.
• The 5-year median for Share-based Compensation is $642000.0 (2022), against an average of $4.0 million.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation slumped 223.05% in 2023, then surged 4300.0% in 2024.
• TuHURA Biosciences' Share-based Compensation stood at $907000.0 in 2022, then slumped by 64.17% to $325000.0 in 2023, then soared by 4300.0% to $14.3 million in 2024, then sank by 128.62% to -$4.1 million in 2025, then soared by 622.94% to $21.4 million in 2026.
• Business Quant data shows HURA's Share-based Compensation at $21.4 million in Q1 2026, -$4.1 million in Q4 2025, and $11.0 million in Q3 2025.